A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile

Facility #6, Rome

Facility #1, Brussels

Facility #1, Edegem

Royal Brisbane and Women's Hospital, Brisbane

Facility #2, Namur

Facility #1, Badalona

Facility #2, Barcelona

Facility #1, The Bronx

Facility #1, Bucharest

Facility #1, Caen

Facility #2, Philadelphia

Facility #1, Philadelphia

Facility #1, Washington D.C.

Facility #6, Milan

Facility #7, Milan

Facility #1, Dijon

Facility #1, Dijon

Facility #1, Madrid

Facility #1, Málaga

Facility #1, Hanover

Facility #1, Bordeaux

Facility #1, Columbus

Facility #1, Essen

Facility #1, Ann Arbor

Facility #1, Detroit

Facility#1, Busan

Facility #2, Angers

Facility #2, Pisa

Facility #1, Livorno

Facility #2, Lyon

Facility #1, Tübingen

Facility #1, Paris

Facility #1, Torrance

Facility#1, La Jolla

Facility #1, San Diego

Facility #2, Villejuif

Facility #1, Würzburg

Facility #1, Portland

Facility #1, Seattle

Facility #3, Moscow

Facility #4, Moscow

Facility #4, Saint Petersburg

Facility #3, Saint Petersburg

Facility #1, Obninsk

Facility #1, Cluj-Napoca

Facility #1, Boston

Facility #2, Boston

Facility#2, Morristown

Facility#1, Summit

Facility #1, Darlinghurst

Facility #1, Saint Leonards

Facility#2, Chermside

Facility #1, Herston

Facility #1, Melbourne

Facility #1, Nedlands

Facility #1, Melbourne

Facility #1, Saint Leonards

Facility #1, Namur

Facility #1, Calgary

Facility #1, Toronto

Facility #1, Québec

Facility #1, Strasbourg

Facility #1, Bordeaux

Facility #1, Angers

Facility #1, Villejuif

Facility #1, Caen

Facility #1, Essen

Facility #2, Essen

Facility #1, Leipzig

Facility #1, Petah Tikva

Facility #1, Rome

Facility #2, Rome

Facility #3, Rome

Facility #2, Milan

Facility #3, Milan

Facility #4, Milan

Facility #5, Milan

Facility #1, Pisa

Facility #4, Roma

Facility #2, Rozzano

Facility #1, Torino

Facility #1, Viagrande

Facility #2, Kielce

Facility #1, Moscow

Facility #2, Moscow

Facility #1, Saint Petersburg

Facility #2, Saint Petersburg

Facility #1, Goyang-si

Facility #1, Seoul

Facility #2, Seoul

Facility #1, Barcelona

Facility #2, Madrid

Facility #2, Madrid

Facility #3, Madrid

Facility #1, London

Facility #1, Glasgow

Facility #1, Odense

Facility #3, Seoul

Facility #4, Seoul

Facility #1, Gothenburg

Facility #1, Lund